Dr. Bishayee is the Director of Research and Professor of Pharmacology at the Lake Erie College of Osteopathic Medicine (Bradenton, Florida). Dr. Bishayee has more than 25 years combined experience in pharmaceutical and biomedical education, research, teaching, and administration. He received his Bachelor of Pharmacy (B.Pharm.), Master of Pharmacy (M.Pharm.), and Ph.D. (cancer prevention) from Jadavpur University, Kolkata, India. Dr. Bishayee performed post-doctoral research at Rutgers University, Newark, New Jersey (formerly University of Medicine and Dentistry of New Jersey) and completed a fellowship in Academic Medicine from Northeast Ohio Medical University (NEOMED, Rootstown, Ohio). Dr. Bishayee’s primary research interest during last two decades encompasses natural products and dietary agents in health and disease. His laboratory is involved in investigating cancer preventive and therapeutic effects of medicinal plants, natural products, dietary and synthetic agents using various pre-clinical models of cancer and underlying mechanisms of action. The various projects of Dr. Bishayee are funded by the National Institutes of Health as well as private pharmaceutical and biotechnological companies. Dr Bishayee has been awarded a United States patent on development of a potential drug for breast cancer prevention and treatment. Dr. Bishayee has published more than 300 peer-reviewed original research papers and authoritative review articles, mostly in high-impact journals, including Nature Reviews Drug Discovery [impact factor (IF) 120.1], Biotechnology Advances (IF 16.0), Trends in Food Science and Technology (IF 15.3), Seminars in Cancer Biology (IF 14.5), Acta Pharmaceutica Sinica B (IF 14.5), Pharmacology and Therapeutics (IF 13.5), Medicinal Research Reviews (IF 13.3), Cancer Treatment Reviews (IF 11.8), Critical Reviews in Food Science and Nutrition (IF 10.2), Biochimica et Biophysica Acta - Reviews on Cancer (IF 11.2), Clinical and Translational Medicine (IF 10.6), Cancer Letters (IF 9.7), Advances in Nutrition (IF 9.3), Cancer and Metastasis Reviews (IF 9.3), and Pharmacological Research (IF 9.3); 22 book chapters; and around 90 conference abstracts, and delivered more than 30 invited presentations at various national and international scientific meetings. Dr. Bishayee is an editorial board member of various reputed journals, such as Pharmacological Research, Phytomedicine (Elsevier), Frontiers in Oncology (Frontiers Media S.A.), Frontiers in Pharmacology, Cancers (MDPI), BMC Complementary and Alternative Medicine (Springer Nature), Current Molecular Pharmacology (Bentham Science), and Anti-Cancer Drugs (Wolters Kluwer) and reviewer of more than 80 reputed journals. Dr. Bishayee edited an Elsevier book “Epigenetics of Cancer Prevention” and guest edited several special issues on natural products and cancer published by leading publishers, such as Elsevier, Springer Nature, MDPI, and Bentham. Dr. Bishayee is a “Highly Cited Researcher” in 2022 and his papers rank in the top 1% by citations for a field or fields (Clarivate, Web of Science). His Scopus h-index is 75 and scholars from all over the world have cited Dr. Bishayee’s published work more than 25,000 times.

Jingwei Xie received his B.S. (1999) and M.S. (2002) from Nanjing University of Technology, China, and his Ph.D. from the National University of Singapore (2007). He worked as a postdoctoral fellow in the Xia group at Washington University in St. Louis (2007‐2010). He is currently a Professor in the Department of Surgery-Transplant and Holland Regenerative Medicine Program at the University of Nebraska Medical Center (UNMC). He has won several prestigious awards including Most Promising New Invention Award at UNMC (2017), Maurer Scientific Achievement Award (2019), CAB Mid-Career Investigator Award (2020), and Distinguished Scientist Award at UNMC (2021). He was recently selected as 2024 AIMBE Fellow. His research interests include biomaterials, drug delivery, wound healing, hemostasis, and regenerative medicine.

Paula Ferreira is a Coordinator Researcher at the University of Aveiro, CICECO – Aveiro Institute of Materials. She has been Principal and Co- Investigator on more than 16 research project awards and 10 projects with industry. She has a vast experience as a supervisor, with 33 MSc students (currently 3), 16 PhD students (currently 10) and 12 Post-doctoral fellows. Her publishing history counts over 200 scientific papers, with over 3223 citations (h-index 33). She participated in over 110 international conferences delivering more than 60 oral presentations. She is/was involved in 4 FCT-CNRS and 1 Pessoa bilateral cooperation agreements and 10 COST actions (5 as participant of the working groups and 5 as member of the management committee). She has been collaborating with several Portuguese Researchers and foreigner Researchers within Europe. She participated on the organizing committee of 9 International Scientific Meetings on Materials Science topics.

The research interests involve the synthesis, structural and physical characterization, and processing of nanofunctional and nanoporous materials for microelectronics and energy applications by bottom-up approaches. She is also interested in sustainable functional bionanocomposites for flexible devices application.

Changyou Gao He is a Cheung Kong Scholar of Ministry of Education of China, a winner for the National Science Fund for Distinguished Young Scholars of China, a fellow of the International Federation of Biomaterial Science and Engineering Societies, the American Institute of Medicinal and Biological Engineering, the Royal Society of Chemistry, and the Chinese Society of Biomaterials. He is now serving as an associate president of Chinese Society of Biomaterials, and an associate editor of Biomaterials Advances and Progress in Materials Science. His research interests include self-adaptive biomaterials, immuno-modulation biomaterials, anti-bacterial biomaterials and their applications in tissue repair and regeneration. He has published more than 500 papers with an H-index of 78.

Susana Olhero is nowadays Assistant Professor and member of the Executive Board of the Department of Materials and Ceramics Engineering (DEMaC)/University of Aveiro, and a research member of CICECO - Aveiro Institute of Materials. The focus of her research has been the development of 3D structures by near net shaping colloidal-based techniques, including additive manufacturing of various functional ceramics for several applications, including bio-implants. Her knowledge and experience in this area has been consolidated by several indicators including publications, projects and supervisions.

Dr. Michele Bianchi completed his Ph.D. in Chemical Sciences in 2011 at the “Alma Mater Studiorum” University of Bologna, Italy. In 2012 he was a Visiting Researcher in the biomaterial group of Prof. John Jansen (Radboud University Medical Center, Nijmegen, The Netherlands). Until 2018 he was Research Associate at the Rizzoli Orthopedic Institute (Bologna, Italy), then he was Researcher at the Italian Institute of Technology (Ferrara, Italy) up to 2022. The same year he was appointed Assistant Professor at the University of Modena and Reggio Emilia, where he is currently in charge of General Chemistry and Advanced Biomaterials teachings. His research focuses on the investigation of cell migration and differentiation in microstructured environments under the application of external stimuli such as electrical and mechanical ones. He has published more than 70 peer-reviewed publications in the biomaterials/bioelectronics field and his work has been presented at more than 60 national and international conferences, including several invited talks. He is also inventor of 3 patents and co-founder of the start-up company “Organic Bioelectronics”. He is currently member of the Early Career Editorial Board of “Bioactive Materials” (KeAi). He has been responsible for several nationally and European funded projects dealing with biomaterials and cell interfaces for regenerative medicine.